Overview
Nexalin Technology develops wearable, non-invasive neurostimulation devices targeting the hypothalamus to treat anxiety, insomnia, and opioid use disorder without drugs or side effects.
More in Neuromodulation
Latest industry news
Nurosym Launches Wearable VNS Device as Neuromodulation Interest Reaches New Heights
2026-11-06 · Product
Brain-Computer Interface Project Aims to Build a Google Map of the Human Brain
2026-11-05 · Research
Migraine Device Delivers Drug-Free Relief for Veterans in New Clinical Study
2026-11-04 · Research
Tether Evo Research Targets Signal Longevity, One of Brain-Computer Interfaces' Hardest Unsolved Problems
2026-11-03 · Research
Company details
Category
⚡ Neuromodulation
Location
Houston, Texas, USA
Funding
Publicly traded (NASDAQ: NXLI)
Website
nexalin.comListed
2026-11-02
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →